By Michele Maatouk
Date: Monday 02 Feb 2026
(Sharecast News) - GSK is planning to cut as many as 350 jobs in research & development in the UK and US, it was announced on Monday.
| Director/PDMR Shareholding | 02-Feb-2026 | 16:02 | RNS |
| Total Voting Rights | 02-Feb-2026 | 16:00 | RNS |
| BLOCK LISTING SIX MONTHLY RETURN | 02-Feb-2026 | 16:00 | RNS |
| Form 8.3 - NCC Group plc | 02-Feb-2026 | 15:20 | RNS |
| Form 8.3 - Oxford Biomedica plc | 02-Feb-2026 | 15:20 | RNS |
| Questor:Meggitt | 23-Dec-2014 | Telegraph |
| Questor :KCOM | 27-Nov-2014 | Telegraph |
| Questor :Ricardo | 31-Oct-2014 | Telegraph |
| Questor:CSR | 17-Oct-2014 | Telegraph |
| Questor:BAE Systems | 03-Sep-2014 | Telegraph |
| Price | 5,945.63 |
| Closing Price Change | 15.98 |
| % Change | 0.00 % |
| 02-Feb-26 Close | 5,945.63 |
You are here: research